epirubicin has been researched along with Cirrhosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bergler-Klein, J; Gugerell, A; Gyöngyösi, M; Jakab, A; Lukovic, D; Maurer, G; Pavo, N; Pils, D; Pircher, A; Riesenhuber, M; Spannbauer, A; Traxler, D; Winkler, J; Zlabinger, K | 1 |
| Chen, Y; Huang, X; Liu, C; Qu, K; Qu, P; Wu, Y; Xing, J; Xu, X; Yan, Z; Yuan, P; Zhang, H; Zhang, J | 1 |
| Han, Q; Hu, R; Irwin, DM; Li, H; Man, Z; Mao, Y; Niu, G; Tan, H; Wang, X; Zhang, J; Zhang, Q; Zhang, X | 1 |
| Biondo, D; D'Antoni, A; Fili', D; Gridelli, B; Luca, A; Maruzzelli, L; Miraglia, R; Petridis, I; Pietrosi, G; Riccardo, V; Vizzini, GB | 1 |
| Arriagada, R; Bourgier, C; Dunant, A; Heymann, S; Marsiglia, H; Mathieu, MC; Pessoa, EL; Spielmann, M; Uzan, C | 1 |
| Cuschieri, A; Hastie, K; Ramesar, K | 1 |
6 other study(ies) available for epirubicin and Cirrhosis
| Article | Year |
|---|---|
Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiotoxicity; Cells, Cultured; Collagen; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Drug Compounding; Epirubicin; Female; Fibrosis; Humans; Interferon Regulatory Factors; Myocytes, Cardiac; Polyethylene Glycols; Sus scrofa; Transcriptome; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling | 2020 |
Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
Topics: Adult; Aged; Animals; Carcinoma, Hepatocellular; Cell Hypoxia; Chemoembolization, Therapeutic; Disease Models, Animal; Disease Progression; Epirubicin; Female; Fibrosis; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Infusions, Intra-Arterial; Liver; Liver Cirrhosis, Experimental; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Rats, Sprague-Dawley | 2015 |
Xinmailong mitigated epirubicin-induced cardiotoxicity via inhibiting autophagy.
Topics: Animals; Autophagy; Cardiotonic Agents; Cardiotoxicity; Collagen; Disease Models, Animal; Drugs, Chinese Herbal; Epirubicin; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Expression Regulation; Heart Diseases; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinase 9; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Stroke Volume; Time Factors; Tissue Inhibitor of Metalloproteinase-4; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2016 |
Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Comorbidity; Dose-Response Relationship, Drug; Epirubicin; Female; Fibrosis; Humans; Italy; Liver Neoplasms; Male; Middle Aged; Prevalence; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Treatment Outcome | 2009 |
Exclusive alternating chemotherapy and radiotherapy in nonmetastatic inflammatory breast cancer: 20 years of follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachial Plexus Neuropathies; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fibrosis; Fluorouracil; Follow-Up Studies; Heart; Humans; Inflammatory Breast Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Radiation Pneumonitis; Survival Rate; Tamoxifen; Time Factors; Vincristine | 2012 |
Local and systemic effects of repeated intraperitoneal epirubicin treatment.
Topics: Animals; Epirubicin; Fibrosis; Infusions, Parenteral; Isotonic Solutions; Male; Peritoneal Diseases; Peritoneum; Peritonitis; Rats; Rats, Inbred Strains; Sodium Chloride; Tissue Adhesions | 1991 |